As filed with the Securities and Exchange Commission on March 13, 2023
Registration No. 333-265050
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
SANOFI
(Exact name of
Registrant as specified in its charter)
|
|
|
| Republic of France |
|
Not Applicable |
| (State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification Number) |
46, avenue de la Grande Armée, 75017 Paris, France
(Address of Registrant’s principal executive offices)
ACTION 2022 SHAREHOLDING PLAN
(Full title of the plan)
Debora C. Pellicano
Vice President and Chief Financial Officer
Sanofi U.S. Services Inc.
55 Corporate Drive
Bridgewater, New Jersey 08807
Tel. No. +1 (908) 981-5000
(Name, address and telephone number of agent for service)
Copies to:
Sami
Toutounji
Gide Loyrette Nouel A.A.R.P.I.
15 rue de Laborde
75008
Paris, France
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “small reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
| Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
| Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐